Abstract: This review describes a new enzymatic method for in vitro glycogen synthesis and its structure and properties. In this method, short-chain amylose is used as the substrate for branching enzymes (BE, EC 2.4.1.18). Although a kidney bean BE and Bacillus cereus BE could not synthesize high-molecular weight glucan, BEs from 6 other bacterial sources produced enzymatically synthesized glycogen (ESG). The BE from Aquifex aeolicus was the most suitable for the production of glycogen with a weight-average molecular weight (Mw) of 3,000-30,000 k. The molecular weight of the ESG is controllable by changing the concentration of the substrate amylose. Furthermore, the addition of amylomaltase (AM, EC 2.4.1.25) significantly enhanced the efficiency of this process, and the yield of ESG reached approximately 65%. Typical preparations of ESG obtained by this method were subjected to structural analyses. The average chain length, interior chain length, and exterior chain length of the ESGs were 8.2-11.6, 2.0-3.3, and 4.2-7.6, respectively. Transmission electron microscopy and intrinsic viscosity measurement showed that the ESG molecules formed spherical particles. Unlike starch, the ESGs were barely degraded by pullulanase. Solutions of ESG were opalescent (milky-white and slightly bluish), and gave a reddishbrown color on the addition of iodine. These analyses revealed that ESG shares similar molecular shapes and solution properties with natural-source glycogen. Moreover, ESG had macrophage-stimulating activity and its activity depends on the molecular weight of ESG. We successfully achieved large scale production of ESG. ESG could lead to new industrial applications, such as in the food, chemical, and pharmaceutical fields.
Glycogen
Glycogen is the storage form of glucose in animals, fungi, bacteria, yeasts, and archaea. The polysaccharide is a highly branched (1→4)(1→6)-linked α-d-glucan with a high molecular weight (10 6 -10 9 ) (Geddes 1986 ). Based on the results of electron microscopy, it has been shown that glycogen consists of spherical particles with diameters of 20-40 nm (β-particles), and that the β-particles often associate into much larger α-particles (∼200 nm). The molecular weight of an individual β-particle has been shown to be approximately 10 7 (Geddes 1986) . Glycogen aqueous solution is opalescent (milky-white and slightly bluish), and gives a reddishbrown color on the addition of iodine. Amylopectin, a major component of starch, is also a highly branched (1→4)(1→6)-linked α-d-glucan. However, the degree of branching, namely the number of (1→6)-α-d-glucosidic linkages, in glycogen is about twice that in amylopectin. A glycogen-type polymer, referred to as phytoglycogen, has also been isolated from several higher plants. In animal tissues, glycogen is synthesized from UDP-glucose via the cooperative action of glycogenin (EC 2.4.1.186), glycogen synthase (EC 2.4.1.11), and branching enzyme (BE, 1,4-α-d-glucan:1,4-α-d-glucan 6-α-d-(1,4-α-glucano)-transferase, EC 2.4.1.18).
Glycogen isolated from animal tissues or shellfish has been used to stimulate the exudation of phagocytic cells into the peritoneal cavities of experimental animals in immunological studies (Thorpe & Marcus 1967; Mantovani 1981) . It has also been reported that glycogen has an antitumor effect, probably through its immunomodulating activity, and that this activity seems to depend on the fine structure of glycogen (Takaya et al. 1998; Takaya 2000) . Glycogen has long been considered to have health benefits as a food ingredient. As revealed below, we demonstrated that enzymatically synthesized glycogen (ESG) has a stimulating activity on immunocompetent cells, such as macrophages. Glycogen has also been used as a raw material in the cosmetic industry and as a carrier to enhance the yield of DNA during precipitation with organic solvent (Heath et al. 2001) .
In vitro synthesis of glycogen
Extraction of glycogen from natural resources such as animal tissues or shellfishes is laborious and costly process. Therefore, in vitro synthesis may be possible answer to obtain glycogen in industrial scale. Actually, the in vitro synthesis of glycogen has been successfully achieved by the combined action of α-glucan phosphorylase (GP, EC 2.4.1.1) and BE using glucose-1-phosphate (G-1-P) as a substrate (GP-BE method) about 70 years ago. (Cori & Cori 1943) . At that time, enzymes were extracted from animal tissues and costly. Additionally, GP from animal tissues is allosteric enzyme and need to be phosphorylated or added an activator (glucose-6-phosphate) (Fukui et al. 1982) . However, microbial or plant enzymes have been developed and used for the in vitro synthesis by many researchers (e.g., Tolmasky & Krisman 1987; Fujii et al. 2003; van der Vlist et al. 2008 ). The ESG produced by the GP-BE method has properties similar to those of the natural-source glycogen (NSG) (Kitahata & Okada 1988) . UDP-glucose, a natural substrate for in vivo glycogen synthesis, was also used as substrate by using glycogen synthase and BE as catalysts (Parodi et al. 1969) . Although both G-1-P and UDP-glucose are expensive for industrial applications, the former could be obtained from the inexpensive substrate sucrose by using sucrose phosphorylase (SP, EC 2.4.1.7) (SP-GP-BE method) (Ohdan et al. 2006) . Furthermore, we have demonstrated that ESG produced by the SP-GP-BE method has immunomodulating activity (Ryoyama et al. 2004 ). However, the yield of glycogen from sucrose was less than 40%, and a more efficient method is required to meet the demand for glycogen for industrial applications.
In the GP-BE and SP-GP-BE methods, GP elongates a chain of α-(1→4)-glucan and BE introduces branch points in the growing chains, mimicking the in vivo synthesis of glycogen by glycogen synthase and BE. Then, a question has come up. Can we synthesize glycogen simply using amylose as a substrate? The published results to date have all been negative: BE can synthesize branched glucans but their molecular weights are much lower than that of glycogen. For example, Praznik et al. (1992) reported that the action of potato BE on amylose with a weight-average molecular weight (M w ) of 67.6 k resulted in a branched product with a M w of 33.5 k. Boyer et al. (1982) analyzed the action of maize BE isozyme I by gel filtration chromatography and observed that the product was eluted more slowly than the substrate. Kitamura (1996) , using light-scattering analyses, also reported that potato BE brought about a decrease in the molecular weight of the substrate amylose. We have reported that Bacillus cereus BE produced branched glucan with a M w of 50 k from amylose with M w of 320 k (Takata et al. 2005) . The decreases in the molecular weight of the substrate can be attributable to a cyclization reaction by BE; it has been demonstrated that BE catalyzes a cyclization reaction in addition to a branching reaction in vitro. As a result of cyclization, the molecular weight of the substrate should be decreased. By contrast, an inter-chain branching reaction results in both larger and smaller molecules if two molecules of the same size are used as a substrate. An intra-chain branching reaction should not change the molecular weight. However, most studies have used BE from plant sources and relatively long-chain amyloses were used as the substrate. To evaluate the possibility of glycogen synthesis from amylose, we tested the activity of eight types of BE from various sources using relatively short-chain amyloses as the substrates. We found that some BEs from bacterial sources can synthesize glycogen (ESG). We then compared some of the properties of the ESG with those of NSG. Furthermore, we found that ESG has physiological function.
Actions of BEs from several sources on amyloses
To evaluate the possibility of producing glycogen from amylose, we tested the actions of BEs from eight sources on short-chain amyloses using high-performance sizeexclusion chromatography with a multi-angle laser light scattering photometer and a differential refractive index detector (HPSEC-MALLS-RI) ). The substrates used were Amylose A (M n , numberaverage molecular weight, 2.9 k; Nacalai Tesque, Inc., Kyoto, Japan) and Amylose AS-10 (M w , 10 k; Nakano Vinegar Co., Ltd., Aichi, Japan). In this analysis system, the peak for short-chain amylose given by the RIdetector overlapped the peak for the salts in the reaction buffer. However, if glucan with a high molecular weight (>1,000 k) is produced, its peak could be easily detected. Table 1 summarizes the results. In the reaction mixtures including kidney bean BE and Bacillus cereus BE, no high molecular weight glucans were detected. However, glucans with M w more than 1,000 k were detected in the mixtures including other BEs. Rhodothermus obamensis BE gave glucans with an extremely high molecular weight, whereas Aquifex aeolicus BE produced glucan that was similar in size to the β-particles of NSG. A. aeolicus BE was selected for further analyses.
The high-molecular-weight glucan produced by this method (Fig. 1) can be considered to be ESG, because the properties and structures of the products were similar to those of NSGs as described later.
From a practical standpoint, Amylose A is preferable to Amylose AS-10, since the former can be easily obtained by treating starch with isoamylase (IAM), although the yield of ESG from Amylose A was lower than that from Amylose AS-10.
Effect of amylomaltase
In order to solve the problem of low yield of ESG, we added amylomaltase (AM, EC 2.4.1.25) from Thermus aquaticus to the reaction mixture. The addition of AM to the reaction mixture significantly improved the yield of ESG . The yield reached 64% under optimal conditions. How to control the molecular weight of ESG After debranching of partially degraded starch, maltodextrin (DE 8-9.5), by using IAM, we used it at various concentrations as the substrate for BEs in the synthesis of ESGs . At a higher substrate concentration, the M w values of ESGs were lower. By changing the concentration of substrate, we can control the M w of ESGs.
Structures of ESG
We synthesized ESGs (A-I) under various reaction conditions, and compared the properties and structures of the ESGs with those of NSGs (Table 2) (Kajiura et al. , 2010 . The fine structural parameters of glycogen were the average chain length, the exterior chain length, and the interior chain length (Hata et al. 1984; Manners 1991) . The structures of NSGs depend on the source and extraction method, and therefore they show structural heterogeneity (Table 2 ). The average chain lengths of ESGs (A-I) tended to be slightly shorter than those of NSGs, whereas exterior chain lengths and interior chain lengths were within the variations of the values for NSGs (Table 2) . On the other hand, the unit-chain distributions of ESGs and NSGs as analyzed by high-performance anion exchange chromatography after IAM treatment were slightly different from each other (Takata et al. 2009 ): NSGs have larger amounts of long unit chains (degree of polymerization (DP): 25- 
35) than ESGs. In other words, ESGs have narrower unit-chain distributions than NSGs.
Appearance of aqueous solution Figure 2a shows a comparison of the solutions of amylopectin, maltodextrin, NSG from rabbit liver and ESG-F. The solution of maltodextrin was clear/colorless, whereas the solution of amylopectin was cloudy. By contrast, the solutions of glycogens (NSG from rabbit liver and ESG-F) were opalescent, as described by Manners (1991) . All ESGs listed in Table 2 were easily soluble in water and the aqueous solutions were also opalescent, resembling NSGs (data not shown). Furthermore, FigFig. 3 . 5% (w/v) aqueous solutions of ESGs.
ure 2b shows the comparison of the solutions with the addition of iodine. The solutions of amylopectin and maltodextrin turned dark blue and dark purple colors, respectively. By contrast, the solutions of NSG from rabbit liver and ESG-F turned a reddish-brown color. NSG and ESG showed similar color reaction with iodine.
The larger the molecular size, the deeper were the opalescent colors of the aqueous solutions of ESGs (Fig. 3) . The colors of the NSG solutions also depended on their molecular sizes (data not shown). The concentration of ESG also affected the depth of color (Fig. 4) . In the concentration range of 1-10% (w/v), the higher the concentration, the deeper was the color. However, in the range of 10-20% (w/v), the color of the solution became lighter. Similar phenomena were also observed for the NSG solutions (data not shown). 
Image of transmission electron microscopy (TEM)
According to TEM images (Fig. 5) , both ESG and NSG have a slightly distorted circular shape, with diameters of 20-40 nm (Kajiura et al. 2010) . The shapes and sizes were in good agreement with those of β-particles previously reported by Hata et al. (1983) . In the image of NSG, a few large and irregular shaped particles with diameters of around 80-100 nm were found. These large particles may be aggregates of smaller particles, since it is known that the β-particles sometimes associate to form larger α-particles (60-200 nm) with a rosette-like appearance (Kjoelberg et al. 1963; Manners 1991) . In the image of ESG, aggregated forms (α-particles) of glycogen were not found.
Intrinsic viscosity of ESG
We determined the intrinsic viscosities of glycogens by using a capillary viscometer of Ubbelohde type. The intrinsic viscosities of ESGs and NSGs were very low (around 8 mL/g), and showed no molecular weight dependence (Kajiura et al. 2010) . By contrast, Kitamura et al. (1989) and Kitamura (1996) demonstrated that the intrinsic viscosities of amylose and amylopectin increase with their molecular weights. The intrinsic viscosity result suggested that ESG molecules behave as hard spheres in solution, resembling the behavior of NSG.
Digestibility of ESG
Digestibilities of maltodextrin, NSGs and ESGs were investigated according to an in vitro digestion method (Okada et al. 1990; Hashimoto et al. 2006) (Tables 3, 4) . All polysaccharides were not digested by artificial gastric juice. Glycogens were digested by human salivary α-amylase, porcine pancreatic α-amylase, and rat small intestinal mucosa enzymes, the hydrolysis rates were 46-62%, 44-55%, and 60-75%, respectively. Maltodextrin was found to be digested easier than glycogens, as expected from its lower degree of branching. The digestibility of ESG was seemed to be lowest among these polysaccharides.
Susceptibility of ESG to pullulanase and α-amylase
Pullulanase (EC 3.2.1.41) hydrolyzes α-1,6 linkages of α-1,4/1,6 glucans such as pullulan, starch, and glycogen. However, it has been shown that the enzyme only partially hydrolyzes glycogen, trimming its outermost branches (Kitahata 1995) . Glycogen synthesized by the GP-BE method was shown to be resistant to pullulanase (Boyer & Preiss 1977; Kitahata & Okada 1988 ). Therefore, we tested the pullulanase susceptibilities of the ESG and NSG (Fig. 6) (Kajiura et al. , 2010 . Waxy corn starch was easily degraded into small fragments by pullulanase. However, NSG from oyster and the ESG-B were barely degraded. This result indicates that the ESG was similar to NSG, but was unlike amylopectin. Furthermore, we tested the susceptibility of ESG by excess amounts of α-amylase (Takata et al. 2009 ). The final products of α-amylase hydrolysis of NSG were glucose, maltose, maltotriose, branched oligosaccharides with DP≥4, and highly branched macrodextrin molecules with molecular weights of up to 10 k. In the final products of α- a Reducing sugars were measured by the dinitrosalicylic acid method (Takata et al. 2009 ). amylase hydrolysis of ESGs, we detected much larger macrodextrins (molecular weight >1,000 k). In contrast to NSG, oligosaccharides with DP 4-7 could not be detected in the ESG hydrolysates. These results suggest that the α-1,6 linkages in ESG molecules are more regularly distributed than those in NSG molecules. ESG is synthesized in much simpler circumstances than NSG, in which no trimming reactions occur during the synthetic process. This simplicity can result in a regular internal structure without long spans between α-1,6 linkages.
Physiological function of ESG
Glycogen is well known as the energy and carbon reserves in animal cells and microorganisms. In addition to this role, some reports have suggested that glycogen has an immunological activity (Thorpe & Marcus 1967; Mantovani 1981; Takaya et al. 1998 ). However, strong scientific evidence has not been obtained for the immunomodulating activity. Indeed, many scientists have been annoyed by the lack of reproducibility of their experimental results. This lack of reproducibility may be because their samples of glycogen have been extracted from natural resources, as (1) the effect of trace amounts of other materials cannot be ruled out, and (2) important characteristics of each glycogen sample, such as the average molecular mass and the chain length, are quite different depending on the source and purification procedures. We have clarified the immunological activity of glycogen by using completely pure ESG with very uniform characteristics (Kakutani et al. 2007 . First, we examined the immunestimulating effect of ESG on NO (nitric oxide) production using RAW264.7, a murine macrophage cell line. The result showed glycogen enhanced NO production of RAW264.7 (Fig. 7) . The immunostimulatory activity of glycogen relates closely to its molecular weight and reaches to the highest at around 5,000 k-6,500 k. Next, the peritoneal-exudate cells collected from C3H/HeJ mice, Toll-like receptor 4 mutants, were also activated by ESGs with similar profiles as RAW264.7 (Kakutani et al. 2007 ). Furthermore, we demonstrated by flow cytometry that biotinylated ESGs bound the macrophage cell line (Kakutani et al. 2007 . These results strongly suggested that glycogen functions not only as a fuel reservoir, but also as a signaling factor in vivo.
Conclusion and future prospects
We have developed a novel method (IAM-BE-AM method) for producing glycogen from short-chain amylose by using BE. This method has two advantages compared with the SP-GP-BE method, in which sucrose is used as a starting material. First, the yield of glycogen is higher. The yield of glycogen by the SP-GP-BE method was less than 40%, whereas that by the IAM-BE-AM method reached 65% under the optimal conditions. Second, the molecular weight of glycogen is controllable within the range of 3,000-30,000 k by changing the concentration of substrate. The structures and properties of the ESGs were quite similar to those of NSGs. Despite these similarities, there were two differences (the unit-chain distribution and final products by α-amylase hydrolysis) between the ESG and NSG. Furthermore, we have demonstrated that ESG has immunomodulating activity. We hypothesize that the macromolecule fraction after partial hydrolysis of ESG that reaches the intestinal tract stimulates immunocompetent cells resulting in the health benefits. Investigations in vivo are now in progress to gain a further understanding of the effect of orally administered glycogen.
